GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (NAS:INMD) » Definitions » Marketable Securities

InMode (InMode) Marketable Securities : $649.6 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is InMode Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. InMode's Marketable Securities for the quarter that ended in Mar. 2024 was $649.6 Mil.

InMode's annual Marketable Securities increased from Dec. 2021 ($347.8 Mil) to Dec. 2022 ($449.8 Mil) and increased from Dec. 2022 ($449.8 Mil) to Dec. 2023 ($597.2 Mil).


InMode Marketable Securities Historical Data

The historical data trend for InMode's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMode Marketable Securities Chart

InMode Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial 148.64 191.60 347.78 449.84 597.19

InMode Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 481.49 469.56 542.11 597.19 649.61

InMode Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


InMode  (NAS:INMD) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


InMode Marketable Securities Related Terms

Thank you for viewing the detailed overview of InMode's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


InMode (InMode) Business Description

Traded in Other Exchanges
Address
Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, ISR, 2069206
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.